We provide you with 20 years of free, institutional-grade data for SEER stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of SEER. Explore the full financial landscape of SEER stock.
| Reported Date | CIK | Ticker | Type |
|---|
Seer, Inc(NASDAQ:SEER) 
Seer, Inc., a life sciences company, engages in developing and commercializing products for researchers to unlock biological information. The company develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that provides workf...
Website: https://seer.bio/
Founded: 2017
CEO: Omid Farokhzad
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report about SEER stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.